ArticleEuropean radiology2021

CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.

S Colagrande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.